The Sonic hedgehog signaling pathway is activated in pancreatic tumor CSCs, and sanguinarine has been shown to play a role in the secondary pathway, while sanguinarine upregulates E-cadherin and inhibits N-cadherin to inhibit the EMT process and prevent pancreatic cancer progression. The gene discussed is CDH2; the disease is pancreatic neoplasm.